Status:
COMPLETED
Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis
Lead Sponsor:
Washington University School of Medicine
Conditions:
Lymphatic Filariasis
Soil Transmitted Helminth Infections
Eligibility:
All Genders
5+ years
Brief Summary
Approximately 3,500 people will participate per year. The study population will include females and males over 5 years of age who live in filariasis endemic areas. The study will be performed in Indon...
Detailed Description
Lymphatic filariasis (LF) is a deforming and disabling infectious disease that causes elephantiasis and genital deformity (especially hydroceles). The infection affects some 120 million people in 81 c...
Eligibility Criteria
Inclusion
- Areas should be endemic for filariasis and have limited or no prior experience with MDA. Males and Females greater than or equal to 5 years of age.
Exclusion
- Children less than 5 years of age.
Key Trial Info
Start Date :
May 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
17108 Patients enrolled
Trial Details
Trial ID
NCT01905423
Start Date
May 1 2011
End Date
December 1 2015
Last Update
November 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Indonesia, Department of Parasitology
Jakarta, Java, Indonesia, 10430